Literature DB >> 12663789

Complexes of poliovirus serotypes with their common cellular receptor, CD155.

Yongning He1, Steffen Mueller, Paul R Chipman, Carol M Bator, Xiaozhong Peng, Valorie D Bowman, Suchetana Mukhopadhyay, Eckard Wimmer, Richard J Kuhn, Michael G Rossmann.   

Abstract

Structures of all three poliovirus (PV) serotypes (PV1, PV2, and PV3) complexed with their cellular receptor, PV receptor (PVR or CD155), were determined by cryoelectron microscopy. Both glycosylated and fully deglycosylated CD155 exhibited similar binding sites and orientations in the viral canyon for all three PV serotypes, showing that all three serotypes use a common mechanism for cell entry. Difference maps between the glycosylated and deglycosylated CD155 complexes determined the sites of the carbohydrate moieties that, in turn, helped to verify the position of the receptor relative to the viral surface. The proximity of the CD155 carbohydrate site at Asn105 to the viral surface in the receptor-virus complex suggests that it might interfere with receptor docking, an observation consistent with the properties of mutant CD155. The footprints of CD155 on PV surfaces indicate that the south rim of the canyon dominates the virus-receptor interactions and may correspond to the initial CD155 binding state of the receptor-mediated viral uncoating. In contrast, the interaction of CD155 with the north rim of the canyon, especially the region immediately outside the viral hydrophobic pocket that normally binds a cellular "pocket factor," may be critical for the release of the pocket factor, decreasing the virus stability and hence initiating uncoating. The large area of the CD155 footprint on the PV surface, in comparison with other picornavirus-receptor interactions, could be a potential limitation on the viability of PV escape mutants from antibody neutralization. Many of these are likely to have lost their ability to bind CD155, resulting in there being only three PV serotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663789      PMCID: PMC152153          DOI: 10.1128/jvi.77.8.4827-4835.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.

Authors:  P R Kolatkar; J Bella; N H Olson; C M Bator; T S Baker; M G Rossmann
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  Distinct cellular receptor interactions in poliovirus and rhinoviruses.

Authors:  L Xing; K Tjarnlund; B Lindqvist; G G Kaplan; D Feigelstock; R H Cheng; J M Casasnovas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

3.  Two distinct binding affinities of poliovirus for its cellular receptor.

Authors:  B M McDermott; A H Rux; R J Eisenberg; G H Cohen; V R Racaniello
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

4.  Three-dimensional structure of poliovirus receptor bound to poliovirus.

Authors:  D M Belnap; B M McDermott; D J Filman; N Cheng; B L Trus; H J Zuccola; V R Racaniello; J M Hogle; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Interaction of the poliovirus receptor with poliovirus.

Authors:  Y He; V D Bowman; S Mueller; C M Bator; J Bella; X Peng; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.

Authors:  E Hendry; H Hatanaka; E Fry; M Smyth; J Tate; G Stanway; J Santti; M Maaronen; T Hyypiä; D Stuart
Journal:  Structure       Date:  1999-12-15       Impact factor: 5.006

7.  The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.

Authors:  E A Hewat; E Neumann; J F Conway; R Moser; B Ronacher; T C Marlovits; D Blaas
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

8.  Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.

Authors:  C Xiao; C M Bator; V D Bowman; E Rieder; Y He; B Hébert; J Bella; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis.

Authors:  M Gromeier; D Solecki; D D Patel; E Wimmer
Journal:  Virology       Date:  2000-08-01       Impact factor: 3.616

10.  Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.

Authors:  J Harber; G Bernhardt; H H Lu; J Y Sgro; E Wimmer
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

View more
  39 in total

1.  Poliomyelitis: historical facts, epidemiology, and current challenges in eradication.

Authors:  Man Mohan Mehndiratta; Prachi Mehndiratta; Renuka Pande
Journal:  Neurohospitalist       Date:  2014-10

2.  Structure of MHC-Independent TCRs and Their Recognition of Native Antigen CD155.

Authors:  Jinghua Lu; François Van Laethem; Ingrid Saba; Jonathan Chu; Anastasia N Tikhonova; Abhisek Bhattacharya; Alfred Singer; Peter D Sun
Journal:  J Immunol       Date:  2020-04-22       Impact factor: 5.422

3.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Single particle cryoelectron tomography characterization of the structure and structural variability of poliovirus-receptor-membrane complex at 30 A resolution.

Authors:  Mihnea Bostina; Doryen Bubeck; Cindi Schwartz; Daniela Nicastro; David J Filman; James M Hogle
Journal:  J Struct Biol       Date:  2007-08-24       Impact factor: 2.867

5.  Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.

Authors:  Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Vaia Pliaka; Christine Kottaridi; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Dimitri Komiotis; Panayotis Markoulatos
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

6.  Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.

Authors:  Ping Zhang; Steffen Mueller; Marc C Morais; Carol M Bator; Valorie D Bowman; Susan Hafenstein; Eckard Wimmer; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

7.  Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.

Authors:  Zhaochun Chen; Elizabeth R Fischer; Diana Kouiavskaia; Bryan T Hansen; Steven J Ludtke; Bella Bidzhieva; Michelle Makiya; Liane Agulto; Robert H Purcell; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

8.  Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus.

Authors:  Christopher M Robinson; Palmy R Jesudhasan; Julie K Pfeiffer
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

9.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

Authors:  Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van der Avoort
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.